Safety Extension Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis
Clinical trial NCT03482752 · TERMINATED
Trial details
- NCT number
- NCT03482752
- Sponsor
- Savara Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-16
- Primary completion
- 2021-01-14
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.